MSD Launches Injectable Version of Deep Mycosis Drug Noxafil

July 22, 2020
MSD’s deep mycosis treatment Noxafil for Intravenous Infusion 300 mg (posaconazole) hit the shelves in Japan on July 21, following a 100 mg tablet version that was rolled out in April. The drug is indicated for 1) the prevention of...read more